Related Experiment Video

Updated: Jun 14, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.5K

The Medical Research Council/British Heart Foundation Centre of Research Excellence in Advanced Cardiac Therapies

Andrew H Baker1,2,3, Paul R Riley4,5, Mauro Giacca6,7

  • 1British Heart Foundation Centre for Research Excellence, Institute for Neuroscience and Cardiovascular Research, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.

European Heart Journal
|November 9, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Genotyping and Quantification of In Situ Hybridization Staining in Zebrafish
05:41

Genotyping and Quantification of In Situ Hybridization Staining in Zebrafish

Published on: January 28, 2020

10.2K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.6K

Related Experiment Videos

Last Updated: Jun 14, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.5K
Genotyping and Quantification of In Situ Hybridization Staining in Zebrafish
05:41

Genotyping and Quantification of In Situ Hybridization Staining in Zebrafish

Published on: January 28, 2020

10.2K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.6K

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Articles linked to this work by shared authors, journal, and citation graph.

Atherosclerotic plaque fibroblasts derive from adventitial and medial Pdgfra-lineage-positive cells and predominantly maintain fibroblast identity.

Cardiovascular research·2026

The dark genome in cardiovascular medicine.

European heart journal·2026

Mechanoreceptor plexin D1 regulates lymphatic valve morphogenesis and lymphedema pathogenesis.

The Journal of clinical investigation·2026

Osr1-expressing mesoderm contributes to lymphatic vessel assembly and complexity in the mammalian kidney.

Cell reports·2026

Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction.

Cardiovascular research·2026

Mechanical load inhibits cancer growth in mouse and human hearts.

Science (New York, N.Y.)·2026

Implementation of cardiac magnetic resonance imaging in everyday cardiology practice.

European heart journal·2026

Acute cellular rejection after heart transplantation: validation of HEARTBiT, a transcriptomic biomarker.

European heart journal·2026

Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes.

European heart journal·2026

Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial.

European heart journal·2026

Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation.

European heart journal·2026

Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction.

European heart journal·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us